Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Moderna CEO on New Flu Vaccine, Curing Cancer
11:54am, Wednesday, 13'th Sep 2023
Stephane Bancel, Moderna CEO, talks about seeking regulatory approval for a new version of its influenza vaccine, and new ways to treat and detect cancer. He speaks on "Bloomberg Markets.
Moderna stock rises on positive results in flu vaccine trial
11:50am, Wednesday, 13'th Sep 2023
Moderna (MRNA) shares are ticking up this morning after the pharmaceutical company published positive data from its latest flu vaccine trial. Yahoo Finance Health Care Reporter Anjalee Khemlani outlin
Options Bulls Blast Moderna Stock on Vaccine Tailwinds
10:41am, Wednesday, 13'th Sep 2023
Moderna Inc (NASDAQ:MRNA) stock is up 6.5% to trade at $112.09 at last check, after a late-stage trial of its flu vaccine induced a stronger immune response against all four A and B strains of the
Moderna CEO eyes $8 billion in sales for 2023: ‘Covid is not going away'
09:44am, Wednesday, 13'th Sep 2023
The CEO of Moderna Inc. (NASDAQ: MRNA) showed optimism for the company in a recent interview for Squawk Box on CNBC, foreseeing between $6 billion to $8 billion in sales in 2023, as their COVID-19 boo
Moderna CEO: Covid is not going away
09:17am, Wednesday, 13'th Sep 2023
Moderna CEO Stéphane Bancel joins 'Squawk Box' to discuss the company's new Covid-19 booster vaccine, their new products for cancer treatment, and more.
New Covid vaccines could reach Americans as soon as Thursday – here's what you need to know
09:03am, Wednesday, 13'th Sep 2023
Updated Covid vaccines from Pfizer and Moderna will soon be administered at pharmacies, and many other locations across the U.S.
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
08:19am, Wednesday, 13'th Sep 2023
Moderna compared the flu vaccine, dubbed mRNA-1010, to a currently approved seasonal flu vaccine from GlaxoSmithKline called Fluarix.
Moderna Stock Rises on Positive Results From Flu Vaccine
08:00am, Wednesday, 13'th Sep 2023
Moderna expects to launch up to 15 new products over the next five years 'addressing high unmet needs.'
Moderna to scale down manufacturing of COVID vaccine
06:38am, Wednesday, 13'th Sep 2023
Moderna on Wednesday announced it was scaling down manufacturing of its COVID-19 vaccine, an updated version of which was approved this week by U.S. regulators, to align with lower post-pandemic deman
Moderna aims to prove it's ‘more than a COVID company'
06:32am, Wednesday, 13'th Sep 2023
As it looks to expand its horizons beyond COVID-19 vaccines, Moderna Inc. MRNA, -0.53% on Wednesday released positive results from a late-stage trial of an mRNA flu vaccine and signaled progress acros
The 3 Most Undervalued Biotech Stocks to Buy in September 2023
09:22pm, Tuesday, 12'th Sep 2023
It's been a difficult time for biotechnology stocks. After a boom during the Covid-19 pandemic, the entire sector appears to have been abandoned by investors.
CDC advisors recommend updated Covid vaccines for all Americans ages 6 months and up
04:00pm, Tuesday, 12'th Sep 2023
CDC Director Mandy Cohen still has to sign off on the panel's recommendation before the new Pfizer and Moderna Covid vaccines become available nationwide.
CDC advisers recommend updated COVID shots for people 6 months of age and older
03:59pm, Tuesday, 12'th Sep 2023
Advisers to the Centers for Disease Control and Prevention voted Tuesday to recommend updated COVID-19 vaccines for people 6 months of age and older. The 13-to-1 vote comes just one day after the U.S.
Moderna, Inc. (MRNA) Morgan Stanley 21st Annual Global Healthcare Conference (Transcript)
03:10pm, Tuesday, 12'th Sep 2023
Moderna, Inc. (NASDAQ:MRNA ) Morgan Stanley 21st Annual Global Healthcare Conference September 12, 2023 12:15 PM ET Company Participants Stephane Bancel - CEO Conference Call Participants Terence Flyn
Moderna (MRNA), Immatics Ink Deal to Develop New Cancer Therapies
01:35pm, Tuesday, 12'th Sep 2023
The deal will combine Moderna (MRNA) and Immatics' (IMTX) proprietary platforms to develop innovative immunotherapies for cancer.
